Florian Huemer

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Topics

Metastatic Colorectal Cancer

Mesenchymal Stem Cells

Chronic Lymphocytic Leukemia

Top Venues

Journal of clinical medicine

Wiener klinische Wochenschrift

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Konstantin Schlick, Antonia Gantschnigg, Alexander Seymer, Florian Huemer, Richard Greil, Lukas Weiss
Comparison of gemcitabine plus oxaliplatin versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma: A single-center retrospective analysis. Cancer medicine (2023)
Ronald Heregger, Florian Huemer, Markus Steiner, Alejandra Gonzalez-Martinez, Richard Greil, Lukas Weiss
Unraveling Resistance to Immunotherapy in MSI-High Colorectal Cancer. Cancers 15 (20) (2023)
Falk Roeder, Sabine Gerum, Stefan Hecht, Florian Huemer, Tarkan Jäger, Reinhard Kaufmann, Eckhard Klieser, Oliver Owen Koch, Daniel Neureiter, Klaus Emmanuel, Felix Sedlmayer, Richard Greil, Lukas Weiss
How We Treat Localized Rectal Cancer-An Institutional Paradigm for Total Neoadjuvant Therapy. Cancers 14 (22) (2022)
Florian Huemer, Michael Leisch, Roland Geisberger, Nadja Zaborsky, Richard Greil
miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Teresa Magnes, Sandro Wagner, Aaron R Thorner, Daniel Neureiter, Eckhard Klieser, Gabriel Rinnerthaler, Lukas Weiss, Florian Huemer, Konstantin Schlick, Nadja Zaborsky, Markus Steiner, Richard Greil, Alexander Egle, Thomas Melchardt
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies. Cancers 13 (4) (2021)
David Lang, Anna Brauner, Florian Huemer, Gabriel Rinnerthaler, Andreas Horner, Romana Wass, Elmar Brehm, Bernhard Kaiser, Richard Greil, Bernd Lamprecht
Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy-A Retrospective Bi-Centric Cohort Study. Cancers 14 (1) (2021)
Florian Huemer, Gudrun Piringer, Verena Schlintl, Hubert Hackl, Gabriel Rinnerthaler, Josef Thaler, Richard Greil, Lukas Weiss
Hospitalizations and Clinical Outcome in Metastatic Colorectal Cancer During Regorafenib or TAS-102 Therapy. Cancers 12 (10) (2020)
Florian Huemer, Eckhard Klieser, Daniel Neureiter, Verena Schlintl, Gabriel Rinnerthaler, Franck Pagès, Amos Kirilovsky, Carine El Sissy, Wolfgang Iglseder, Franz Xaver Singhartinger, Tarkan Jäger, Adam Dinnewitzer, Nadja Zaborsky, Markus Steiner, Richard Greil, Lukas Weiss
Impact of PD-L1 Scores and Changes on Clinical Outcome in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy. Journal of clinical medicine 9 (9) (2020)
Florian Huemer, Michael Leisch, Roland Geisberger, Thomas Melchardt, Gabriel Rinnerthaler, Nadja Zaborsky, Richard Greil
Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence. International journal of molecular sciences 21 (8) (2020)
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Hubert Hackl, Markus Steiner, Claudia Monzo-Fuentes, Thomas Melchardt, Teresa Magnes, Florian Huemer, Theresa Westphal, Clemens Hufnagl, Cornelia Hauser-Kronberger, Alexander Egle, Richard Greil
Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial. Journal of clinical medicine 9 (6) (2020)
Florian Huemer, Thomas Melchardt, Bettina Jansko, Adam Wahida, Stefanie Jilg, Philipp J Jost, Eckhard Klieser, Katja Steiger, Teresa Magnes, Lisa Pleyer, Sigrun Greil-Ressler, Christof Rass, Richard Greil, Alexander Egle
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM. European journal of haematology 102 (5) (2019)
Florian Huemer, Lukas Weiss, Viktoria Faber, Daniel Neureiter, Alexander Egle, Klaus Geissler, Daniela Voskova, Armin Zebisch, Sonja Burgstaller, Angelika Pichler, Reinhard Stauder, Wolfgang Sperr, Alois Lang, Michael Pfeilstöcker, Sigrid Machherndl-Spandl, Margarete Stampfl, Richard Greil, Lisa Pleyer
Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia. Wiener klinische Wochenschrift 130 (3-4) (2018)